(Q28252988)

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Mechanism of NAD(P)H:Quinone reductase: Ab initio studies of reduced flavin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Structure-Based Development of Anticancer Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

INDUCED PROTECTION OF ADRENAL CORTEX AGAINST 7,12-DIMETHYLBENZ(ALPHA)ANTHRACENE. INFLUENCE OF ETHIONINE. INDUCTION OF MENADIONE REDUCTASE. INCORPORATION OF THYMIDINE-H3.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

DT-diaphorase and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Mechanisms of action of quinone-containing alkylating agents. I: NQO1-directed drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Effect of butylated hydroxyanisole on the toxicity of 2-hydroxy-1,4-naphthoquinone to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Is alpha-tocopherol a reservoir for alpha-tocopheryl hydroquinone?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Regulation of JNK signaling by GSTp

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NQO1 stabilizes p53 through a distinct pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

A note on the inhibition of DT-diaphorase by dicoumarol

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Re: Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Presence of a heterozygous substitution and its relationship to DT-diaphorase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Comparison of DNA adduct levels associated with oxidative stress in human pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Benzene, NQO1, and genetic susceptibility to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes in the Danish population. DIEGG and DSGD. Danish IDDM Epidemiology and Genetics Group and The Danish Study Group of Diabetes in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Interethnic differences of drug-metabolizing enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Susceptibility factors and DNA adducts in peripheral blood mononuclear cells of aluminium smelter workers exposed to polycyclic aromatic hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Polymorphism of metabolic genes and susceptibility to occupational chronic manganism

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982008-1

7 January 2021

10.1016/S0076-6879(04)82008-1

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1849389

1849389

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference